Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Amgen Inc (AMGN)

2014-12-18@16:49:56 ET
Watch for Amgen to Potentially Pullback After Gaining 3.06% Yesterday (PSM)

2014-12-18@16:49:26 ET
Watch for Amgen to Potentially Pullback After Gaining 3.06% Yesterday (PSM)

2014-12-18@15:37:57 ET
Daily Dividend Report: AMGN, ZTS, WDR, IRC, SCHL, KYE (MNV)

2014-12-18@14:00:29 ET
Amgen (AMGN) Approaches New Upside Target of $167.44 (F79)

2014-12-18@08:07:20 ET
Amgen's board reports 30% rise in Q1 2015 dividend (MTO)

2014-12-18@05:20:31 ET
Cancer Pain - Pipeline Review, H1 2014 (MTO)

2014-12-18@05:15:26 ET
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2014 (MTO)

2014-12-18@05:05:57 ET
Apotex receives FDA acceptance for pegfilgrastim (DTM)

2014-12-18@04:24:42 ET
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:24:32 ET
Metastatic Melanoma - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:19:15 ET
Post Menopausal Osteoporosis - Pipeline Review, H1 2014 (MTO)

2014-12-17@21:53:13 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-12-17@21:32:56 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-12-17@21:20:07 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-12-17@20:36:54 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-12-17@17:45:00 ET
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend (PRN)

2014-12-17@10:23:00 ET
Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Pegfilgrastim (PRN)

2014-12-17@09:32:08 ET
Amgen (AMGN) Trading Near $166.76 Resistance Level (FBM)

2014-12-16@15:01:01 ET
Research and Markets: Asia Pacific Osteoporosis Drugs (Antiresorptives & Anabolics) Market 2015-2019 with Amgen, Eli Lilly, Merck & Novartis Dominating (BIZ)